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Impact of Artificial Intelligence on Pharma Industry
Pooja Borisa, Debjani Singh, Kamal Singh Rathore*
Email: kamalsrathore@gmail.com

Abstract
The pharma sector is undergoing a lot of advancement with the advent of artificial intelligence. Many
pharmaceutical companies are adapting this technology in order to improve the drug discovery and development
phase, hence this would help them undertake various research oriented projects pertaining to novel drug delivery
approaches. The speed with which this system works will reduce the time lag between the development of a
drug product and its commercialization. The Artificial Neural Network systems (ANN) are being developed to
predict relationships within the data. Machine learning and Deep learning are also being used to study different
parameters of machines and modulate them accordingly to get the desired output. Thus, the Artificial Intelligence
softwares function as efficient systems in designing a drug product. They are also being used in clinical trials for
generation and interpretation of data collected from patient’s information. Hence, in this article we discuss the
various roles of artificial intelligence in drug development, tablet manufacturing, design of antibiotic peptides
and clinical research. Therefore, this gives a clear picture that artificial intelligence has an efficient impact on
pharma industry.
Key words: ADME (Absorption, Distribution, Metabolism and Excretion), AI (Artificial Intelligence), AI
Software, AI in Pharma industry, ANN (Artificial Neural Network), CT (Computed Tomography), DL (Deep
Learning), DNN (Deep Neural Network), GAN (Generative Adversarial Networks), GP (Genetic Programming),
HTS (High Throughput Screening), ML (Machine Learning), MRI (Magnetic Resonance Imaging), 3N-MCTS
(Monte Carlo Tree Search), RASAR (Red Across Structural Activity Relationship)

Introduction
Artificial Intelligence (AI) has brought a prominent
revolution in pharmaceutical industries. It is being
majorly utilized in each and every field of healthcare.
In the current scenario, many pharma companies
are facing major obstacles in the discovery and
development of drugs due to scarcity of resources
for research and its high cost. Therefore, AI
technology is a boon for efficient drug development1.
This technology is a culmination of human
intelligence and computer processing. It is an
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advanced version of computer aided technique that
consists of collecting the information from various
sources, then preparing rules accordingly to be
followed for handling the required information, and
drawing possible outcomes to determine appropriate
results and conclusions. Various statistical tools
are being employed in AI so that the computer
software and processes can resemble the human
behaviour. It consists of subunits such as machine
learning and deep learning which provide ease in
working with neural networks. Starting from the
identification of hit series to the determination of
lead molecule and finally, the formulation of drug
molecule including clinical trials, all these involve
the artificial intelligence techniques. Thus, it is of
utmost importance for bringing more innovation in
the pharmaceutical sector, rendering more accurate
and rapid production of medicines2.
Neural networks are a type of computational and
mathematical models that derive the relationships
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of the given data amongst it without the need to
generate any previous knowledge of the desired
data from its user. It does not give any predictions
but produce a range of outcomes that would best
suit the experimental data and therefore comply
with its given criteria. Further, this technique is
modified to develop Artificial Neural Networks
(ANN) that is worthwhile in tackling problems
related to pharmaceutical research, development and
formulation3.
The optimization process can be suitably conducted
with another form of artificial intelligence
technology called as fuzzy logic. It simplifies the
complicated concepts and involves data mining and
presenting the information in an easy format so that
the user can directly interpret it, and devise actions
accordingly by formulating rules that would serve
as guidance for conducting the progress of work
efficiently and developing future prospects1.
2. Role of artificial intelligence in drug
development
Due to larger chemical space, the bridge between
drug discovery and development is growing larger
day by day as finding of novel drug molecules is
becoming tedious and difficult. Thus, the techniques
which work on the fundamentals of artificial
intelligence provide great benefits in different phases
of development of drug; such as identifying and
validating targets of drugs, modelling of drugs and
improving their druggable properties. It also plays a
pivotal role in designing clinical trials for patients,
hence, optimizes the strategy for making decisions4.
One of its application called as, “Open Targets” is
a new strategic program to study the relationship
of drug targets with diseases and the way genes
are linked to diseases. It provides a path that would
guide in identifying target associated with disease or
else the disease which is related to the target4.
The drug like molecule must comply with the
Lipinski’s rule of five. Keeping this in consideration,
a new neural network technique called as 3N-MCTS
(Monte Carlo Tree Search) developed by Seglar et al.
has an edge over the retro synthesis computer aided
systems. Through this, different routes of synthesis

were being devised in a short span of time with
reduction in the number of steps to be followed5.
SPIDER is an AI approach which is being used for
determining the role of natural products and their
utilization in drug discovery. It was constructed to
mainly predict the targets for drug molecules e.g.
β-Lapachone, and hence it proved that reversible and
allosteric inhibition of 5-Lipoxygenase is caused by
β-Lapachone. To determine the toxicity of unknown
compounds, a more advanced technique such as Read
Across Structure Activity Relationship (RASAR)
is being used. It is an eminent tool which is being
developed on the basis of creating and identifying
the link between molecular structure and properties
that would lead to toxicity. This is performed with
the aid of database available for the chemicals4.
The Deep Neural Network (DNN) is a system which
includes the framework of neurons artificially being
connected and conducting interactions with them
to carry out different transformations of data. It
develops the criteria for classification of drugs
in their respective therapeutic class based on the
pharmacological and toxicological data. Networks
such as Generative Adversarial Networks (GAN’s)
act as base for developing new generation AI
techniques1.
Artificial Intelligence consists of an important
aspect i.e. Machine Learning (ML). This field is
based on the utilization of statistical attributes.
Machine learning is classified into three sections:
i.

Supervised learning:
It is associated with the development of
predictive approaches which are derived
through the utilization of regression along with
classification methods that give such predictions
through the use of data obtained from input and
output sources. The output data comprise of
diagnostic method of disease in the classification
category, the efficacy of drug and absorption,
distribution, metabolism, excretion (ADME)
predications are categorized in regression
analysis. Thus, both these sub groups provide
extensive information6.

Manipal Journal of Pharmaceutical Sciences | March 2020 | Volume 6 | Issue 1

https://impressions.manipal.edu/mjps/vol6/iss1/9

55

2

Borisa et al.: Impact of Artificial Intelligence on Pharma Industry
Borisa P, et al: Impact of Artificial Intelligence on Pharma Industry

ii. Unsupervised learning:
This approach is entirely focused on input data.
All interpretations are drawn through clustering
and grouping data by employing feature finding
pathways. This type of learning can provide
output data regarding the category of disease
in clustering sub group and the feature finding
sub group would contain data regarding the
origination of target for that disease6.
iii. Re-inforcement learning:
Its major function is related to making decisions
according to the environment and then execute
them to obtain excellent performance. The
output obtained from such type of ML consists
of drug designing through de novo approach, that
is placed in the category of decision making and
the experimental drug design is placed under
the category of execution. Therefore, both can
be attained through the technique of modelling
and by the application of quantum chemistry6.
One more sub field of machine learning has come
into picture i.e. Deep learning (DL) which is based
on the area of artificial neural network that are
provided with the function of adapting and learning
through the use of experimental data which is widely
available. Thus, for the discovery of new molecules,
the data mining approach can be applied to study the
data as well as algorithms could also be generated
to aid in the discovery of any new entity. Thus, DL
can also be employed for identification of genetic
markers and many novel drug molecules. Therefore,
through the application of artificial intelligence,
we can counter various loop-holes pertaining to
pharmaceutical product development. It will also
lead to reduction in the number of drugs failing in
clinical trials and thus accelerate the process of drug
designing and development in a cost effective way6.
2.1 Drug development process
The development of drugs involves a series of
steps. The process is initiated by various techniques
such as High Throughput Screening (HTS) and
computational modelling which provide sources to
generate results. There are two cycles involved in
this process which is going on alternatively and they
are known as inductive and deductive cycles. This
series of cycles ultimately leads to determination
56
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of heat and lead compounds with the desired
specifications. The errors can be minimized in this
process through automation5.
The novel compounds possessing the desired
biological activity are selected and identified in the
step of drug development. This biological activity
can be assessed based on the results of interaction
studies conducted with certain enzymes or
organism. The initial compound that demonstrates
the biological activity in response to a given target
is referred to as “hit” molecule. Libraries of different
chemical compounds are screened to identify hit
molecule. Computer simulation and screening of
various isolated natural products such as bacteria,
plants and fungi are also being utilized to determine
hit molecules. The second step involved in drug
development is lead identification. The lead molecule
has the desired ability of being carried forward
in the development of required drug molecule for
the desired disease. Cell based screening assays
and animal models are being utilized to screen the
generated hit series and therefore they are performed
to predict the safety and efficacy of the compound.
After the determination of lead compound, the
structural modifications are being conducted in
them and their chemical properties are also being
altered to produce a compound that shows minimum
toxicity and optimum therapeutic effect5.
The lead generation step involves the modification
of hit molecules in order to increase their selectivity
and affinity towards the desired target, improve
their biological activity and reduce side effects, and
therefore develop a safe and effective molecule. Then,
hit expansion is carried out to generate analogues
which are chemical compounds obtained from hit
molecules. The building blocks are formed, where
these analogues are further combined together
through a set of various reactions employed
by medicinal chemists. Thus “building block” is
referred to a compound which contain the essential
functional group for interaction with the active site
of the target5. The active site is an area present in
the target which shows specificity towards a specific
molecule and allows the binding of drug molecule
through various interactions. The drug molecule
binding to active site can be explained through “lock
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and key” model. Therefore, AI can be widely utilized
for the following purposes:
• Identification of molecular targets and to
predict the underlying mechanism of drugtarget interaction.
• Determination of hit or lead compound.
• Synthesis of compounds exhibiting drug like
nature.
• Repurposing of drugs.
• Selection of a population for clinical trials.
• Study and determine the mode of action of
drugs.
• Design polypharmacology agents.
3. Modulation of size distribution in granules by
artificial intelligence
Computational Intelligence is being utilized for
developing milling procedures to produce effective
particle size distribution. The dry granulation
method is the most widely used method for the
production of solid type of dosage form. This method
consists of two steps: first is compaction of powder
between two rolls rotating in opposite direction to
create a ribbon and the second is milling process in
which crushing of ribbons lead to the formation of
granules. As particle size is an important feature
in pharmaceutical drug development; in order
to determine and modulate it, various artificial
intelligence technologies are being developed. This
approach is also being used to study various factors
and properties of drug that affect the particle size
and hence the crucial relations are being drawn
through it, like how the properties of material, the
milling parameters, and the prevailing conditions
would affect the size distribution in granules7, 8. The
change in size distribution of granules due to roller
compaction can also be determined by using artificial
intelligence systems that provide the relationship
between the parameters of roller compaction and
their influence on granule size9.
Multiple linear regressions are a computational
method being used for describing the effect of
various independent factors on dependent variables.
Artificial Neural Networks (ANN) method has been
used for selecting the most applicable parameters for
modelling granule size based on the layers criteria,
as a typical ANN is composed of three types of

layers i.e. first is input layer, second is hidden layer
and the third one is output layer. Further, these
layers also contain neurons which are connected to
each other. The signals thus follow the path from
input to output layer via hidden layers. In this model,
a range is selected for each layer and linear scaling is
being followed within the range8.
Genetic Programming (GP) is a type of model
developed on the basis of evolution theory of Darwin
which states the survival of the fittest, thus by
eliminating those individuals that does not fit or are
not capable of surviving in the prevailing conditions.
Hence, selecting and breeding those which are able
to adapt themselves with the conditions and prove
their fitness7.
4. Role of artificial intelligence in clinical
research
It has been observed that a large number of drugs
mostly fail in clinical trials. The percentage of drugs
that enter the market is declining day by day. Certain
drug products pass the clinical trials but when
they are introduced in the market, many problems
arise. Thus, a particular digital platform has to be
developed for resolving such issues. Though artificial
intelligence has many applications, due to lack of
scientific proofs, the use of AI in clinical research
is just theoretical in nature. AI plays a significant
role in clinical research as it has great impact on the
following aspects2:
 Success or failure rate of drug product.
 Reduction in the cost of product development in
terms of absolute values.
 Reduction of time taken by the drug product to
enter the market.
 Decrease in the number of product recalls.
Artificial Intelligence also focuses on the following
three major objectives of clinical research:
 Signals which are predictive and affect the
disease pathology.
 The different steps and methods used for
intervention.
 The effect of time on patient’s condition and the
way in which it defines the quality of life.
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This field thus contains a list of references which
are arranged specifically. These references, along
with figures, confirm the advantage of Artificial
Intelligence over other methods of medical practices.
It is of great use in screening the pathological data of
patients, various lab results of medical examinations
and the drugs being requested based on the patient’s
report. This would help in distinguishing patient’s
condition from normal condition. The artificial
neural network frameworks have been utilied to
study the results of various diagnostic tests such
as magnetic resonance imaging (MRI), X- ray and
Computed Tomography (CT) scan. This system
allows the patient undergoing a clinical trial to enter
data in the mobile phone by himself and provide the
required information, and thus, it develops a direct
contact with the patient. The AI technology can also
be used to predict allergic as well as adverse drug
reactions with the help of its automated softwares
that help in reporting and providing data regarding
any on toward reaction2, 10.
5. Role of artificial intelligence in the design of
peptide antibiotics
The most prevalent issue regarding the use of
antibiotics is the development of multiple antibiotic
resistances that hinders the discovery of antibiotics.
In the present era, small peptides which possess
antimicrobial activity have emerged as a recent
class of antibiotics. In order to design such type of
broad spectrum antibiotics of small peptides, the
information regarding their chemical characteristics
as well as molecular biology is required. The amino
acids containing the active peptides were used to
create two big libraries of 9-amino-acid peptide by
utilizing peptide array technology6.
The data obtained from the above technique was
collected and combined with the Artificial Neural
Networks in order to design in silico models for
antibiotic activity; these models were quantitative in
nature. After their random evaluation, these models
were found to be more promising in determining
the activity of around one lakh peptides. The
peptides demonstrating the best activity against
“Superbugs” were one quartile of the total peptides.
These superbugs are broad array of multidrug
resistance antibiotics. Thus, such peptide antibiotics
58
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can be used for treating various superinfections.
Therefore, the AI can perform enormous function
in designing such novel peptides and hence assist
in the determination of their efficacy and potency.
Broad spectrum antimicrobials are efficiently being
modulated by introducing various amino acid
sequences in peptidic moiety and then re-analyzing
their structure through ANN6.
The AI incorporates a large number of databases
pertaining to small molecules, peptides, amino acids
etc., which can be utilized in the construction as well
as design of novel drug therapeutics for treating
various diseases. The drug – target interactions can
be studied through this approach in order to develop
effective and targeted drug delivery systems. Thus,
these peptide molecules can serve a great potential
to combat drug resistance and therefore can be
utilized to develop effective antibiotics1, 6.

Conclusion
Artificial Intelligence serves as an eminent platform
in the advancement of pharmaceutical sector.
It is widely being employed in drug discovery
and development, thus paving a way for newer
molecules to come into market. It is utilized in
tablet manufacturing procedures such as milling,
compression, dry granulation and other recent
technologies that are being developed for the
production of tablets. It saves time as well as
provides the required set of data for analysis and
quality control. The various components of AI such
as ANN, deep learning, machine learning, genetic
programming etc., are being used for rationale
design of drug molecules as well as peptides. The AI
has also influenced the area of healthcare by playing
a major role in clinical research by predicting the
adverse effects. The information pertaining to the
patient is also being collected through this. Thus,
it provides immediate results and test reports that
would further aid in the determination of optimum
therapy for patient. Therefore, in the upcoming era,
the field of Artificial Intelligence can lead to the
development of various technologies and software
that would help improve the pharmaceutical product
development and health management strategies.
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